Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance

2 Dec 2022

Abstract excerpt

Polycystic ovary syndrome (PCOS) is a common reproductive metabolic disorder, normally accompanied by insulin resistance (IR). The specific pathogenesis of this disease remains unclear. To identify the underlying pathogenesis of PCOS with IR and explore the potential efficacy and mechanism of Jiawei Huanglian-Wendan decoction (JHWD) by a network pharmacology approach. The effective components and the potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lipid metabolism and disorders
Share to Ovarian function and disorders
Share to Pharmacological Effects of Natural Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36482532
DOI: 10.1097/md.0000000000032057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistancePMID 36482532Read ↗

Study on the Mechanisms and Experimental Verification of Cuscuta-Salvia (Tusizi-Danshen) in the Treatment of Polycystic Ovary Syndrome (PCOS) via Network PharmacologySemantic proximity Read ↗

Network Pharmacology-based Strategy for Predicting Active Ingredients and Potential Targets of Coptis Chinensis Franch in Polycystic Ovary SyndromeSemantic proximity Read ↗

Identification of the hub genes in polycystic ovary syndrome based on disease‐associated molecule networkSemantic proximity Read ↗

Network Pharmacology Integrated Molecular Docking Reveals The Mechanism of Huanglian Wendan Decotion Against Metabolic SyndromeSemantic proximity Read ↗

Pharmacological mechanism of Xiaoyao San in the treatment of polycystic ovary syndrome based on network pharmacologySemantic proximity Read ↗

The Mechanism of Jinqi Jiangtang Tablet in Treatment of Type 2 Diabetes Mellitus Based on Network PharmacologySemantic proximity Read ↗

An Investigation Into the Mechanism of Li Chong Pill for Treating Endometriosis Based on Network Pharmacology and Molecular Docking VerificationSemantic proximity Read ↗

Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disordersSemantic proximity Read ↗

A network pharmacology approach to explore the mechanism of HuangZhi YiShen Capsule for treatment of diabetic kidney diseaseSemantic proximity Read ↗

Network Pharmacology-Based Approach to Investigate the Mechanisms of Piwei-Peiyuan Decoction in the Treatment of Gastric CarcinomaSemantic proximity Read ↗

Study on the Mechanism of Bushen Jianpi Decoction in the Treatment of T2DM Based on Network PharmacologySemantic proximity Read ↗

Exploring the Mechanism of Qidan Tongmai Tablets in Anti-Atherosclerosis Based on Network Pharmacology and Molecular DockingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.